Glycopyrrolate Injection
Product Images NDC 51662-1554

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 51662-1554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1554 2 Pouch Labeling)

Pouch Labeling (51662 1554 2 Pouch Labeling)
Glycopyrrolate Injection is a medication used for IM or IV administration containing 0.4mg/2mL glycopyrrolate in a 2mL vial with benzyl alcohol. It is not recommended for newborns and usual dosage should be consulted with the package insert. The medication must be stored at 20°C to 25°C (68°F to 77°F). The original manufacturing NDC code is 0143-9681-25 and the medication can only be obtained with a prescription. The medicine is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275.*
FDA Label Image

Case Labeling (51662 1554 3 Case Labeling)

Case Labeling (51662 1554 3 Case Labeling)
Glycopyrrolate Injection is a medication that comes in a 2mL vial with a strength of 0.2mg/mL or 0.4mg/2mL. It is packaged in boxes of 25 vials and has a shelf life until 2025-01-01. The medication can be administered via IM or IV but should not be used in newborns. Glycopyrrolate Injection requires storage at 20° to 25°C. The manufacturer's package insert provides more details about usual dosage. The medication should be stored at controlled room temperature between 68°F to 77°F (20°C to 25°C). Glycopyrrolate Injection is only available with a prescription, and the original product is manufactured by HF Acquisition Co., LLC in Mukilteo, Washington.*
FDA Label Image

Serialized Label (51662 1554 3 Serialized Labeling)

FDA Label Image

Clinical (Clinical Pharmacology)

FDA Label Image

Description (Description)

FDA Label Image

Vial Label (Vial Labeling)

Vial Label (Vial Labeling)
This is a description of a medication. The medication is Glycopyrrolate which is available in the form of an injection. The injection contains 0.4mg of the medicine per 2 mL of solution. It is for either IV or IM use. The packaging is in a single-dose vial of 2 mL. The product contains benzyl alcohol. The medication is distributed by West-Ward and the lot number and expiry date are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.